Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Orthofix Readies For Bone Protein Product; Cites Hurdles For Acceptance

This article was originally published in The Gray Sheet

Executive Summary

Orthofix is exploring the possibility of conducting clinical trials with its electrical stimulation products and Medtronic's InFuse BMP-2 to demonstrate a benefit for bone morphogenetic protein when used in conjunction with e-stim

You may also be interested in...

Orthofix’ $150 Mil. Breg Purchase Will Produce PoC “Gatekeeper” – CEO

Orthofix will gain access to Breg Inc.'s sales and distribution relationships with general orthopedic offices as part of a $150 mil. acquisition to expand into spinal, reconstruction and trauma orthopedic franchises

Experts Defend UK Agency Over Rapid Authorization Of COVID-19 Vaccine

As arguments rage over whether the UK regulator has rushed its assessment of the Pfizer/BioNTech vaccine, the European Medicines Agency explains why its conditional marketing authorization approach is taking a little longer.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts